PATENT CLAIM ANALYSIS

Application Number: 15887467
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "021200"]

Abstract:
The present invention relates to modified CXCL12 polypeptides, modified CXCL12 locked monomers, and CXCL12 locked dimers. The invention further relates to methods for inhibiting signaling through CXCR4 receptors using the polypeptides of the invention.

Claim (Index 1):
A recombinant CXCL12 polypeptide, the polypeptide comprising a leader sequence operably linked to a CXCL12 polypeptide sequence, wherein 1 to 5 of the first consecutive amino acid residues of the CXCL12 polypeptide sequence are deleted relative to the wild-type CXCL12 sequence.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 88.0
- Lexical Diversity: 1.52
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12380308', '13936650', '12956514', '14736535', '11946676']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.744041630764245
- 35 USC 102 Novelty (BERT): 0.4984299794459912
- Combined Prediction Score: 0.7194804656324196
- Mean Citation Score: 217.162084
- Max Citation Score: 245.77153
- Similarity Product: 179.28329850038708

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test